C37H50N6O7
Neat
690.85
CHEMBL114227; Atazanavir valine analog; 198904-33-5; SCHEMBL6570; X79K9B7G6A; DTXSID501098831; BDBM50066463; 198904-34-6; Atazanavir valine analog {USP IMPURITY]; methyl N-[(1S)-1-[[(1S, 2S)-1-benzyl-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]amino]-[[4-(2-pyridyl)phenyl]methyl]amino]propyl]carbamoyl]-2, 2-dimethyl-propyl]carbamate; ((S)-1-{(1S, 2S)-1-Benzyl-2-hydroxy-3-[N''-((S)-2-methoxycarbonylamino-3-methyl-butyryl)-N-(4-pyridin-2-yl-benzyl)-hydrazino]-propylcarbamoyl}-2, 2-dimethyl-propyl)-carbamic acid methyl ester; 1, 14-Dimethyl (3S, 8S, 9S, 12S)-12-(1, 1-dimethylethyl)-8-hydroxy-3-(1-methylethyl)-4, 11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2, 5, 6, 10, 13-pentaazatetradecanedioate; 1-[4-(Pyridin-2-yl)-phenyl]-4(S)-hydroxy-2-N-(N-methoxycarbonyl-(L)-valyl)amino]-5(S)-N-(N-methoxycarbonyl-(L)-tert-leucyl)amino-6-phenyl-2-azahexane; 2, 5, 6, 10, 13-Pentaazatetradecanedioic acid, 3-(1, 1-dimethylethyl)-8-hydroxy-12-(1-methylethyl)-4, 11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, dimethyl ester, (3S, 8S, 9S, 12S)-; Methyl {(5S, 10S, 11S, 14S)-11-benzyl-5-(tert-butyl)-10-hydroxy-15-methyl-3, 6, 13-trioxo-8-[4-(pyridin-2-yl)benzyl]-2-oxa-4, 7, 8 and 12-tetraazahexadecan-14-yl}carbamate sulfate
methyl N-[(2S)-1-[2-[(2S, 3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3 and 3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3-methyl-1-oxobutan-2-yl]carbamate
InChI=1S/C37H50N6O7/c1-24(2)31(40-35(47)49-6)33(45)42-43(22-26-16-18-27(19-17-26)28-15-11-12-20-38-28)23-30(44)29(21-25-13-9-8-10-14-25)39-34(46)32(37(3,4)5)41-36(48)50-7/h8-20,24,29-32,44H,21-23H2,1-7H3,(H,39,46)(H,40,47)(H,41,48)(H,42,45)/t29-,30-,31-,32+/m0/s1